Alcohol, slow wave sleep, and the somatotropic axis

Alcohol

Volumn 18, Issue 2-3, 1999, Pages 109-122

  Lands, William E M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Cholecystokinin; Cytokines; Leptin; Low dose alcohol; Rapid eye movement (REM) sleep; Slow wave sleep (SWS); Somatostatin; Somatotropin; Thalamus; Withdrawal

Indexed keywords

ALCOHOL; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOSTATIN;

ALCOHOLISM; ARTICLE; DELTA RHYTHM; GROWTH HORMONE RELEASE; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPOTHALAMUS; REM SLEEP; SLEEP PATTERN; SLOW WAVE SLEEP;

ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; SLEEP;

EID: 0032772694     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(98)00073-1     Document Type: Article

References (102)

1. Aalto J., Kiianmaa K. REM-sleep deprivation-induced increase in ethanol intake. Role of brain monoaminergic neurons Alcohol. 3:1986;377-381.
2. Aalto J., Kiianmaa K. Role of brain monoaminergic systems in the increased ethanol drinking caused by REM-sleep deprivation. Alcohol Alcohol. Suppl. 1:1987;313-317.
3. Aguila-Mansilla N., Little B.B., Ho R.H., Barnea A. Differential potencies of cocaine and its metabolites, cocaethylene and benzoylecgonine, in suppressing the functional expression of somatostatin and neuropeptide Y producing neurons in cultures of fetal cortical cells. Biochem. Pharmacol. 54:1997;491-500.
4. Allen R.P., Wagman A.M., Funderburk F.R. Slow wave sleep changes. Alcohol tolerance and treatment implications Adv. Exp. Med. Biol. 85A:1977;629-640.
5. al-Shoumer K.A., Anyaoku V., Richmond W., Johnston D.G. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin. Endocrinol. Oxf. 47:1997;153-159.
6. Anisman H., Kokkinidis L., Borowski T., Merali Z. Differential effects of interleukin (IL)-1 beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Res. 779:1998;177-187.
7. Astrom C. Interaction between sleep and growth hormone. Evaluated by manual polysomnography and automatic power spectrum analysis. Acta Neurol. Scand. 92:1995;281-296.
8. Barb C.R., Yan X., Azain M.J., Kraeling R.R., Rampacek G.B., Ramsay T.G. Recombinant porcine leptin reduces feed intake and stimulates growth hormone secretion in swine. Domest. Anim. Endocrinol. 15:1998;77-86.
9. Bauer J., Hohagen F., Gimmel E., Bruns F., Lis S., Krieger S., Ambach W., Guthmann A., Grunze H., Fritsch-Montero R.et al. Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol. Psychiatry. 38:1995;611-621.
10. Benson K.L., Sullivan E.V., Lim K.O., Lauriello J., Zarcone V.P. Jr., Pfefferbaum A.A. Slow wave sleep and computed tomographic measures of brain morphology in schizophrenia. Psychiatry Res. 60:1996;125-134.
11. Beranek L., Obal F. Jr., Taishi P., Bodosi B., Laczi F., Krueger J.M. Changes in rat sleep after single and repeated injections of the long-acting somatostatin analog octreotide. Am. J. Physiol. 273:1997;R1484-R1491.
12. Brambilla F., Bellodi L., Perna G., Arancio C., Bertani A. Dopamine function in obsessive-compulsive disorder. Growth hormone response to apomorphine stimulation Biol. Psychiatry. 42:1997;889-897.
13. Brown S.A., Inaba R.K., Gillin J.C., Schuckit M.A., Stewart M.A., Irwin M.R. Alcoholism and affective disorder. Clinical course of depressive symptoms Am. J. Psychiatry. 152:1995;45-52.
14. Carro E., Senaris R., Considine R.V., Casanueva F.F., Dieguez C. Regulation of in vivo growth hormone secretion by leptin. Endocrinology. 138:1997;2203-2206.
15. B receptors does not induce sleep and does not affect EEG slow-wave activity and brain temperature in rats. Physiol. Behav. 62:1997;175-179.
16. Cho A.M., Coalson D.W., Klock P.A., Klafta J.M., Marks S., Toledano A.Y., Apfelbaum J.L., Zacny J.P. The effects of alcohol history on the reinforcing, subjective and psychomotor effects of nitrous oxide in healthy volunteers. Drug Alcohol Depend. 45:1997;63-70.
17. Craft P.P., Foil M.B., Cunningham P.R.G., Patselas P.C., Longsnyder B.M., Collier M.S. Intravenous ethanol for alcohol detoxification in trauma patients. South. Med. J. 87:1994;47-54.
18. Cui S.J., Tewari M., Schneider T., Rubin R. Ethanol promotes cell death by inhibition of the insulin-like growth factor I receptor. Alcohol. Clin. Exp. Res. 21:1997;1121-1127.
19. Darko D.F., Miller J.C., Gallen C., White J., Koziol J., Brown S.J., Hayduk R., Atkinson J.H., Assmus J., Munnell D.T.et al. Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA. 92:1995;12080-12084.
20. B receptor agonist. BC-264 on rat sleep Pharmacol. Biochem. Behav. 38:1991;545-548.
21. De Saint Hilaire-Kafi Z., Vallet P.G., Gaillard J.M. Hypnotic action of flunitrazepam is reversed by proglumide in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry. 15:1991;817-823.
22. Dettling M., Heinz A., Dufeu P., Rommelspacher H., Graf K.J., Schmidt L.G. Dopaminergic responsivity in alcoholism - trait, state, or residual marker. Am. J. Psychiatry. 152:1995;1317-1321.
23. Donahoo W.T., Jensen D.R., Yost T.J., Eckel R.H. Isoproterenol and somatostatin decrease plasma leptin in humans. A novel mechanism regulating leptin secretion J. Clin. Endocrinol. Metab. 82:1997;4139-4143.
24. Dossi R.C., Nunez A., Steriade M. Electrophysiology of a slow (0.5-4 Hz) intrinsic oscillation of cat thalamocortical neurones in vivo. J. Physiol. (Lond.). 447:1992;215-234.
25. Ekman A.C., Vakkuri O., Ekman M., Leppaluoto J., Ruokonen A., Knip M. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man. J. Clin. Endocrinol. Metab. 81:1996;2627-2632.
26. Fang J.D., Wang Y., Krueger J.M. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNF alpha treatment. J. Neurosci. 17:1997;5949-5955.
27. 2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics. 7:1997;271-281.
28. Fiorino A.S. Sleep, genes and death. Fatal familial insomnia Brain Res. Brain Res Rev. 22:1996;258-264.
29. Funderburk F.R., Allen R.P., Wagman A.M. Residual effects of ethanol and chlordiazepoxide treatments for alcohol withdrawal. J. Nerv. Ment. Dis. 166:1978;195-203.
30. Gillin J.C., Smith T.L., Irwin M., Kripke D.F., Brown S., Schuckit M. Short REM latency in primary alcoholic patients with secondary depression. Am. J. Psychiatry. 147:1990;106-109.
31. Gillman M.A., Lichtigfeld F.J. Placebo and analgesic nitrous oxide for treatment of the alcoholic withdrawal state. Br. J. Psychiatry. 159:1991;672-675.
32. Gronfier C., Luthringer R., Follenius M., Schaltenbrand N., Macher J.P., Muzet A., Brandenberger G. A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment in delta waves. Sleep. 19:1996;817-824.
33. Hansen M.K., Kapas L., Fang J., Krueger J.M. Cafeteria diet-induced sleep is blocked by subdiaphragmatic vagotomy in rats. Am. J. Physiol. 274:1998;R168-R174.
34. Hansenne M., Pitchot W., Gonzalez Moreno A., Papart P., Timsit-Berthier M., Ansseau M. Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalogr. Clin. Neurophysiol. 96:1995;194-196.
35. Heinz A., Dettling M., Kuhn S., Dufeu P., Graf K.J., Kurten I., Rommelspacher H., Schmidt I.G. Blunted growth-hormone response is associated with early relapse in alcohol-dependent patients. Alcohol. Clin. Exp. Res. 19:1995;62-65.
36. Heinz A., Lichtenberg-Kraag B., Baum S.S., Graf K., Kruger F., Dettling M., Rommelspacher H. Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome. J. Neural Transm. 102:1995;149-157.
37. Heinz A., Dufeu P., Kuhn S., Dettling M., Graf K., Kurten I., Rommelspacher H., Schmidt L.G. Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch. Gen. Psychiatry. 53:1996;1123-1128.
38. 2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity in alcoholism. Alcohol. Clin. Exp. Res. 20:1996;1109-1113.
39. Hill S.Y., Locke J., Zezza N., Kaplan B., Neiswanger K., Steinhauer S.R., Wipprecht G., Xu J. Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol. Psychiatry. 43:1998;40-51.
40. Imatoh N., Nakazawa Y., Ohshima H., Ishibashi M., Yokoyama T. Circadian rhythm of REM sleep of chronic alcoholics during alcohol withdrawal. Drug Alcohol Depend. 18:1986;77-85.
41. Janssen Y.J., Frolich M., Deurenberg P., Roelfsema F. Serum leptin levels during recombinant human GH therapy in adults with GH deficiency. Eur. J. Endocrinol. 137:1997;650-654.
42. Kapas L., Obal F. Jr., Farkas I., Payne L.C., Sary G., Rubicsek G., Krueger J.M. Cholecystokinin promotes sleep and reduces food intake in diabetic rats. Physiol. Behav. 50:1991;417-420.
43. Kapas L., Hansen M.K., Chang H.Y., Krueger J.M. Vagotomy attenuates but does not prevent the somnogenic and febrile effects of lipopolysaccharide in rats. Am. J. Physiol. 274:1998;R406-R411.
44. Kelly D.D. Sleep and dreaming. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of neuroscience. 3rd ed:1991;648-670 Elsevier, New York.
45. Krueger J.M., Takahashi S., Kapas L., Bredow S., Roky R., Fang J., Floyd R., Renegar K.B., Guha-Thakurta N., Novitsky S.et al. Cytokines in sleep regulation. Adv. Neuroimmunol. 5:1995;171-188.
46. Kulkosky P.J. Effect of cholecystokinin octapeptide on ethanol intake in the rat. Alcohol. 1:1984;125-128.
47. Kulkosky P.J., Foderaro M.A., Sandoval S.L., Cesar S.S., Marrinan D.A. Cholecystokinin-induced satiation with ethanol. Effects of lighting cycle and limited access procedures Alcohol. 8:1991;223-227.
48. Landolt H.P., Roth C., Dijk D.J., Borbely A.A. Late-afternoon ethanol intake affects nocturnal sleep and the sleep EEG in middle-aged men. J. Clin. Psychopharmacol. 16:1996;428-436.
49. Lands W.E.M. Cellular signals in alcohol-induced liver injury. A review Alcohol. Clin. Exp. Res. 19:1995;928-938.
50. Lands W.E.M. Alcohol and energy intake. Am. J. Clin. Nutr. Suppl. 62:1995;1101S-1106S.
51. Lands W.E.M. A review of alcohol clearance in humans. Alcohol. 15:1998;147-160.
52. Lugaresi E. The thalamus and insomnia. Neurology. 42(7 Suppl. 6):1992;28-33.
53. Maquet P., Degueldre C., Delfiore G., Aerts J., Péters J.-M., Luxen A., Franck G. Functional neuroanatomy of human slow wave sleep. J. Neurosci. 17:1997;2807-2812.
54. Marshall L., Molle M., Boschen G., Steiger A., Fehm H.L., Born J. Greater efficacy of episodic than continuous growth hormone-releasing hormone (GHRH) administration in promoting slow-wave sleep (SWS). J. Clin. Endocrinol. Metab. 81:1996;1009-1013.
55. Mayo K.E., Godfrey P.A., Suhr S.T., Kulik D.J., Rahal J.O. Growth hormone-releasing hormone. Synthesis and signaling Recent Prog. Horm. Res. 50:1995;35-73.
56. Mayo-Smith M.F. Pharmacological management of alcohol withdrawal - a meta-analysis and evidence-based practice guideline. JAMA. 278:1997;144-151.
57. Merica H., Blois R., Fortune R.D., Gaillard J.M. Evolution of delta activity within the nonREM sleep episode. A biphasic hypothesis Physiol. Behav. 62:1997;213-219.
58. Milner B., Squire L.R., Kandel E.R. Cognitive neuroscience and the study of memory. Neuron. 20:1988;445-468.
59. Mokrani M.C., Duval F., Crocq M.A., Bailey P.E., Macher J.P. Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology. 20:1995;365-375.
60. Montagna P., Cortelli P., Gambetti P., Lugaresi E. Fatal familial insomnia. Sleep, neuroendocrine and vegetative alterations Adv. Neuroimmunol. 5:1995;13-21.
61. Moore M.S., DeZazzo J., Luke A.Y., Tully T., Singh C.M., Heberlein U. Ethanol intoxication in Drosophila. Genetic and pharmacologic evidence for regulation by the cAMP signaling pathway Cell. 93:1998;997-1007.
62. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
63. Nystrom F., Ekman B., Osterlund M., Lindstrom T., Ohman K.P., Arnqvist H.J. Serum leptin concentrations in a normal population and in GH deficiency. Negative correlation with testosterone in men and effects of GH treatment Clin. Endocrinol. (Oxf.). 47:1997;191-198.
64. Obal F. Jr., Bodosi B., Szilagyi A., Kacsoh B., Krueger J.M. Antiserum to growth hormone decreases sleep in the rat. Neuroendocrinology. 66:1997;9-16.
65. Obal F. Jr., Payne L., Kapas L., Opp M., Krueger J.M. Inhibition of growth hormone-releasing factor suppresses both sleep and growth hormone secretion in the rat. Brain Res. 557:1991;149-153.
66. Obal F. Jr., Payne L., Opp M., Alfoldi P., Kapas L., Krueger J.M. Growth hormone-releasing hormone antibodies suppress sleep and prevent enhancement of sleep after sleep deprivation. Am. J. Physiol. 263:1992;R1078-R1085.
67. Payne L.C., Krueger J.M. Interactions of cytokines with the hypothalamus-pituitary axis. J. Immunother. 12:1992;171-173.
68. Pfefferbaum A., Sullivan E.V., Mathalon D.H., Shear P.K., Rosenbloom M.J., Lim K.O. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol. Clin. Exp. Res. 19:1995;1177-1191.
69. Pietrowsky R., Fehm H.L., Er A., Bathelt B., Born J. Influences of the cholecystokinin analog ceruletide on human sleep and evoked potentials. Neuropsychobiology. 23:1990;41-47.
70. Pitchot W., Hansenne M., Moreno A.G., Ansseau M. Growth hormone response to apomorphine in obsessive-compulsive disorder. J. Psychiatry Neurosci. 21:1996;343-345.
71. Prinz P.N., Moe K.E., Dulberg E.M., Larsen L.H., Vitiello M.V., Toivola B., Merriam G.R. Higher plasma IGF-1 levels are associated with increased delta sleep in healthy older men. J. Gerontol. A Biol. Sci. Med. Sci. 50:1995;M222-M226.
72. Quintela M., Senaris R., Heiman M.L., Casanueva F.F., Dieguez C. Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels. Endocrinology. 138:1997;5641-5644.
73. Resnicoff M., Sell C., Ambrose D., Baserga R., Rubin R. Ethanol inhibits the autophosphorylation of the insulin-like growth factor-I (Igf-1) receptor and the IGF-I-mediated proliferation of 3T3 cells. J. Biol. Chem. 268:1993;21777-21782.
74. Rouhani S., Tran G., Leplaideur F., Durlach J., Poenaru S. EEG effects of a single low dose of ethanol on afternoon sleep in the non-alcohol-dependent adult. Alcohol. 6:1989;87-90.
75. Santolaria F., Gonzalez G., Gonzalez-Reimers E., Martinez-Riera A., Milena A., Rodgiguez-Moreno F., Gonzalez-Garcia C. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis. Alcohol Alcohol. 30:1995;703-708.
76. Schmidt L.G., Dettling M., Graef K.J., Heinz A., Kuhn S., Podschus J., Rommelspacher H. Reduced dopaminergic function in alcoholics is related to severe dependence. Biol. Psychiatry. 39:1996;193-198.
77. Sforza E., Montagna P., Tinuper P., Cortelli P., Avoni P., Ferrillo F., Petersen R., Gambetti P., Lugaresi E. Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation. Electroencephalogr. Clin. Neurophysiol. 94:1995;398-405.
78. Soszynski P.A., Frohman L.A. Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat. Endocrinology. 131:1992;2603-2608.
79. SpathSchwalbe E., Hundenborn C., Kern W., Fehm H.L., Born J. Nocturnal wakefulness inhibits growth hormone (GH)-releasing hormone-induced GH secretion. J. Clin. Endocrinol. Metab. 80:1995;214-219.
80. Srivastava V., Hiney J.K., Nyberg C.L., Dees W.L. Effect of ethanol on the synthesis of insulin-like growth factor 1 (IGF-1) and the IGF-1 receptor in late prepubertal female rats. A correlation with serum IGF-1 Alcohol. Clin. Exp. Res. 19:1995;1467-1473.
81. Steiner J.C., LaPaglia N., Hansen M., Emanuele N.V., Emanuele M.A. Effect of chronic ethanol on reproductive and growth hormones in the peripubertal male rat. J. Endocrinol. 154:1997;363-370.
82. Takahashi S., Fang J., Kapas L., Wang Y., Krueger J.M. Inhibition of brain interleukin-1 attenuates sleep rebound after sleep deprivation in rabbits. Am. J. Physiol. 273:1997;R677-R682.
83. Tateishi J., Brown P., Kitamoto T., Hoque Z.M., Roos R., Wollman R., Cervenakova L., Gajdusek D.C. First experimental transmission of fatal familial insomnia. Nature. 376:1995;434-435.
84. Thermos K., Radke J., Kastellakis A., Anagnostakis Y., Spyraki C. Dopamine-somatostatin interactions in the rat striatum. An in vivo micro dialysis study Synapse. 22:1996;209-216.
85. Thompson P.M., Gillin J.C., Golshan S., Irwin M. Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence. Biol. Psychiatry. 38:1995;831-836.
86. Timofeev I., Steriade M. Low-frequency rhythms in the thalamus of intact-cortex and decorticated cats. J. Neurophysiol. 76:1996;4152-4168.
87. Van F., O'Boyle D.J., Hume K.I. Effects of alcohol on the sleep-stage structure of a nap in the afternoon [published erratum appears in Biol. Psychol. 85;1996](Biol. Psychol. 41):1995;55-59.
88. Van F., O'Boyle D.J., Hume K.I. Effects of alcohol on the sleep-stage structure of a nap in the afternoon [published erratum appears in Biol. Psychol. 85;1996](Biol. Psychol. 41):1995;55-59.
89. VanCauter E., Kerkhofs M., Caufriez A., Van Onderbergen A., Thorner M.O., Copinschi G. A quantitative estimation of growth hormone secretion in normal man. Reproducibility and relation to sleep and time of day J. Clin. Endocrinol. Metab. 74:1992;1441-1450.
90. VanCauter E., Plat L. Physiology of growth hormone secretion during sleep. J. Pediatr. 128:1996;S32-S37.
91. VanCauter E., Plat L., Scharf M.B., Leproult R., Cespedes S., L'Hermite-Baleriaux M., Copinschi G. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxy butyrate in normal young men. J. Clin. Invest. 100:1997;745-753.
92. Veldhuis J.D., Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis. predominant impact of age, obesity, gonadal function, and sleep Sleep. 19(10 Suppl.):1996;S221-S224.
93. Vescovi P.P., Coiro V. Persistence of defective serotonergic and GABAergic controls of growth hormone secretion in long-term abstinent alcoholics. Alcohol Alcohol. 32:1997;85-90.
94. Wang Y.H., Tache Y., Sheibel A.B., Go V.L., Wei J.Y. Two types of leptin-responsive gastric vagal afferent terminals. an in vitro single-unit study in rats Am. J. Physiol. 273:1997;R833-R837.
95. Wiesbeck G.A., Davids E., Wodarz N., Thome J., Weijers G., Jakob F., Boening J. Alcohol withdrawal and dopamine receptor sensitivity after prolonged abstinence. Prog. Neuropsychopharmacol. Biol. Psychiatry. 20:1996;1171-1180.
96. 2 dopamine-receptor function as neuroendocrinologically assessed with apomorphine. Drug Alcohol Depend. 40:1995;49-53.
97. Wiesbeck G.A., Mauerer C., Thome J., Jakob F., Boening J. Neuroendocrine support for a relationship between "novelty seeking" and dopaminergic function in alcohol-dependent men. Psychoneuroendocrinology. 20:1995;755-756.
98. Williams H.L., Salamy A. Alcohol and sleep. Kissin B., Begleiter H. The biology of alcoholism. 1972;435-483 Plenum Press, New York.
99. Williams S.R., Turner J.P., Crunelli V. Gamma-hydroxy butyrate promotes oscillatory activity of rat and cat thalamocortical neurons by a tonic GABAB, receptor-mediated hyperpolarization. Neuroscience. 66:1995;133-141.
100. Xu X., Ingram R.L., Sonntag W.E. Ethanol suppresses growth hormone-mediated cellular responses in liver slices. Alcohol. Clin. Exp. Res. 19:1995;1246-1251.
101. Zhang J., Obal F. Jr., Fang J., Collins B.J., Krueger J.M. Non-rapid eye movement sleep is suppressed in transgenic mice with a deficiency in the somatotropic system. Neurosci. Lett. 220:1996;97-100.
102. Zwyghuizen-Doorenbos A., Roehrs T., Timms V., Roth T. Individual differences in the sedating effects of ethanol. Alcohol. Clin. Exp. Res. 14:1990;400-404.